Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Our take

Nucific has enough public detail to investigate, but the final quote and prescription agreement matter more than the minimum-price headline or supplement return policy.

As low as $149/mo; obtain full plan quoteAdvertised $149/month minimum; qualifying plan unclear
InjectionFormat offered
Prescription requiredSubject to clinical evaluation

What stands out

  • Current injectable offer identified
  • Required labs and consultations advertised as included
  • Separate prescription support contact

What to weigh

  • Minimum-price plan conditions unresolved
  • Supplement guarantee is a different policy
  • Confirm sermorelin-specific agreement and clinical group

A current prescription offer, with a qualified price

Nucific’s current homepage lists injectable sermorelin as low as $149 per month. The reviewed listing does not identify the plan length or complete amount required to obtain that minimum. We have left the comparison price unconfirmed rather than treating $149 as a guaranteed one-month purchase.

Ask for a quote showing the chosen treatment, supply duration, first charge and renewal schedule. The same homepage includes multiple medications and supplements, so a number from another treatment should not fill the gap. A useful quote should also explain whether a promotional period ends and what the next refill costs. Those details determine affordability more reliably than the lowest amount in a broad treatment carousel.

Included care needs a product-specific explanation

The homepage says treatment prices include required lab work and provider consultations without a separate membership fee. It also identifies a separate support contact for GLP-1, NAD+ and sermorelin orders. These are useful clues about how the prescription service differs from its supplement business.

Confirm which laboratory tests are required for the sermorelin plan, whether follow-up testing is included and who discusses the results. The published inclusion is broad; it does not establish an individual monitoring schedule. Ask whether you can share existing results or coordinate with another clinician. If another medication is offered alongside sermorelin, obtain its separate price and rationale rather than assuming a combined wellness package is necessary.

Identify who actually provides care

Nucific’s disclosures describe an administrative relationship with independent clinicians and pharmacies, rather than Nucific manufacturing or dispensing medication itself. The homepage names OpenLoop in its GLP-1 clinical disclosure. Because that wording is treatment-specific, confirm the practice and pharmacy responsible for a sermorelin prescription instead of assuming the same arrangement automatically applies.

This separation matters when something needs to change. Billing questions belong with the account team, while laboratory interpretation and prescription decisions need a clinician. Ask where each type of message goes and whether your records can be shared with your usual healthcare professional. An instantly completed eligibility screen is not the same as a completed clinical assessment or a promise that a prescription will follow.

Supplement returns are a separate policy

Nucific’s terms distinguish supplement purchases from prescription services. The supplement section describes a ninety-day money-back guarantee; prescription provisions are more restrictive. The treatment terms discuss seventy-two-hour cancellation notice, limited refunds and reporting damaged or incorrect medication within twenty-four hours. Much of this agreement is framed around GLP-1 services, so obtain the applicable sermorelin contract.

Do not assume a familiar supplement guarantee protects a prescription order. Ask what can be canceled before clinical review, after pharmacy processing and before the next renewal. The answer should identify the product and agreement you are purchasing. Inspect deliveries promptly and retain the label and packaging when reporting a concern, while following the dispensing pharmacy’s advice about whether medication is usable.

Who should investigate Nucific further

Nucific may be relevant to readers who want a single account for prescription wellness care and value advertised laboratory inclusion. The current injectable listing is clear enough to establish an offer, but the qualifying price, clinical assignment and prescription policy still need confirmation. These are meaningful limits on a value comparison.

This review reflects public information checked in October 2026 and no firsthand treatment. Nucific acknowledges that compounded drugs are not FDA-approved. Its healthy-aging and combined-treatment claims should be discussed with a clinician as claims, not guaranteed benefits. I would obtain the exact agreement and monitoring plan before purchasing, particularly if the decision is being influenced by the brand’s separate supplement products or their more generous return language.

Common questions

Does Nucific currently list sermorelin?

Yes. Its current homepage lists sermorelin under an injectable label, advertised as low as $149 per month.

Is $149 a confirmed one-month purchase?

The reviewed listing does not establish the qualifying plan length or full amount due. Obtain a product-specific quote.

Does the supplement money-back guarantee cover sermorelin?

Do not assume so. The terms distinguish supplement returns from prescription services and contain more restrictive prescription provisions.

Explore Nucific

See the current offer and decide whether you want to start a consultation.

Visit Nucific

Reader-supported. We may earn a commission when you use our partner links. How we’re funded

Sources & further reading

Provider prices and terms may change.

  1. Nucific website
  2. FDA: Understanding the risks of compounded drugs
  3. Endocrine Society: Hormones and Aging scientific statement